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sils which may promote the use of breast milk substitutes 
or bottle feeding. It is stated that the presentation of prod-
ucts must clearly express the superiority of breast feeding 
and that no pictures or text may be used that idealize the 
use of infant formula. The Code obliges the member 
states of the World Health Assembly to take appropriate 
measures to promote and implement these principles.
 Countries around the world have implemented mea-
sures to promote the principles and practices laid down 
in the Code  [9] . Also the Global Infant Formula Standard 
of the Codex Alimentarius indicates that the recommen-
dations made in the Code should be taken into account 
 [10] . With regard to Europe, all of the member states of 
the European Union at the World Health Assembly voted 
in favor of adoption of the Code  [11] . Consequently, the 
European Directive on infant formulae and follow-on 
formulae established that ‘the rules of labeling and adver-
tising for these products should be in conformity with the 
principles and the aims of the International Code of Mar-
keting of Breast Milk Substitutes adopted by the 34th 
World Health Assembly’ in an effort to provide better 
protection for the health of infants  [12] . However, the cur-
rent practice in Europe in this regard is far from satisfac-
tory and not in agreement with the European legislation. 
 Three decades ago the ‘International Code of Market-
ing of Breast Milk Substitutes’ (the Code) was adopted by 
the 33rd World Health Assembly, the decision-making 
body of the World Health Organization  [1] . The Code 
aims to protect and promote breast feeding and to ensure 
ethical approaches to marketing of infant formulae and 
other foods that are presented as a partial or total replace-
ment for breast milk. These goals are as timely today as 
ever before given the much increased evidence on the im-
portance of infant feeding for growth, development, and 
long-term health well into adulthood  [2] . Breast feeding 
is widely recognized as the ideal form of infant feeding, 
providing multiple benefits for child health, affecting not 
only immediate health outcomes such as prevention of 
infectious gastroenteritis but also important long-term 
outcomes such as a reduced risk of obesity and atopic ec-
zema, and enhanced cognitive development  [3–8] . Thus, 
breast feeding should be actively promoted, protected, 
and supported. The Code supports the protection of 
breastfeeding and stipulates that there should be no ad-
vertising or other form of promotion of breast milk sub-
stitutes to the general public and that manufacturers and 
distributors should not provide to families, directly or 
indirectly, samples of such products or other gifts of uten-
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Serious infringements of the Code are common, and gov-
ernments often have not taken responsibility for moni-
toring and enforcement of the Code  [11] .
 It is of particular concern that current practices of 
marketing of dietetic products for infants and young chil-
dren are even deteriorating in increasingly violating ap-
propriate professional and ethical standards. This shall 
be demonstrated here by a few recent examples of com-
pletely unacceptable and irresponsible marketing activi-
ties observed in Austria and Germany.
 For example, a global infant formula manufacturer re-
cently initiated and manipulated the development of rec-
ommendations on young child feeding signed by a group 
of pediatricians in Austria, which were then presented to 
the public and to pediatric organizations as if they had 
been independently developed, without disclosing the ac-
tual involvement of a public relations agency that was 
contracted and paid by the global infant formula manu-
facturer to draft the recommendations. Not surprisingly, 
these recommendations, initiated and financed by the 
global infant formula manufacturer, support the use of 
growing-up milks produced by this company. The print-
ed recommendations have since been distributed by this 
company along with glossy brochures and a mouse pad 
advertising these very products, as well as through press 
activities and seminars for health care professionally or-
ganized and financed by the same company, without 
transparent disclosure of the role of interested parties in 
the development of these recommendations. Obviously 
this violates generally accepted professional and ethical 
standards.
 Furthermore, a major infant formula manufacturer 
distributes free packages with an infant feeding bottle 
and nipple in a box labeled with the company advertise-
ments to parents of infants aged 4–6 weeks. This infant 
formula manufacturer also distributes free packages of 
infant formula samples to doctors and midwives for dis-
tribution to young families, which was previously dem-
onstrated to adversely affect breastfeeding rates and du-
ration  [11] . This is clearly an attempt to undermine breast 
feeding of infants during the first weeks and months of 
life while promoting the sales of infant formula, and it 
represents an unethical marketing practice in obvious 
violation of the WHO code as well as the European and 
national legislation.
 Moreover, a major infant formula manufacturer mar-
kets infant formula and follow-on formula products la-
beled on the front of the package with the wording ‘close 
to the model of human milk’. In advertisements in maga-
zines and in television spots addressing the general pub-
lic, a woman breastfeeding her baby is depicted, and the 
accompanying text explains ‘Breastfeeding is a wonder of 
nature. We have come much closer to this wonder through 
a big step’. This statement is factually wrong and misleads 
consumers, because the composition of these products 
with an added oligosugar and a strain of lactic acid pro-
ducing bacteria is not anywhere close to the composition 
of human milk, and there is not even any conclusive sci-
entific evidence available to demonstrate the safety or po-
tential benefits of these products. Moreover, promoting 
these formulae for infants as being similar to human 
milk, in violation of the WHO Code and the European 
and national legislation, may lead parents to believe that 
these formulae would have a benefit comparable to that 
of human milk and hence can undermine breastfeeding.
 Sadly, the protests of the German Society of Pediatrics, 
the German Professional Society of Pediatricians, and the 
German National Breastfeeding Committee to manufac-
turers and to the national and European infant formula 
manufacturer association have not lead to any satisfac-
tory response or change in practice. This is surprising 
since it would appear to be in the long-term interest of the 
industry itself to comply with appropriate ethical stan-
dards because only then can they expect to achieve sus-
tainable commercial success. It is perhaps even more 
frustrating that the food safety authorities charged with 
surveillance of compliance with the dietetic food law have 
been informed about the violations against valid legisla-
tion but so far have not acted at all.
 One can only agree with a recent comment by Prof. 
Stewart Forsyth who wrote that ‘there is need for a more 
transparent governance structure that has clearly defined 
responsibilities for ensuring that there are reliable and 
sustainable systems in place that will underpin the effec-
tive delivery of the Code’  [13] . Three decades after the 
unanimous adoption of the International Code of Mar-
keting of Breast Milk Substitutes, it is high time that gov-
ernments of European countries accept their responsibil-
ity to consistently implement the principles of the Code 
in order to support the health and well-being of our chil-
dren.
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